MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 79 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2020. The put-call ratio across all filers is 4.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,000 | +20.0% | 2,206 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -28.6% | 2,206 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -12.5% | 2,206 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -38.5% | 2,206 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $13,000 | -18.8% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -5.9% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $17,000 | +41.7% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -29.4% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $17,000 | +13.3% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $15,000 | -46.4% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $28,000 | +55.6% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | +28.6% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $14,000 | +7.7% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,000 | 0.0% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | -35.0% | 2,206 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | +100.0% | 2,206 | +77.0% | 0.00% | – |
| Q1 2017 | $10,000 | – | 1,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 449,500 | $1,429,000 | 0.58% |
| Opaleye Management Inc. | 767,400 | $2,440,000 | 0.48% |
| FRAZIER MANAGEMENT LLC | 550,000 | $1,749,000 | 0.16% |
| FEDERATED HERMES, INC. | 9,610,200 | $30,560,000 | 0.07% |
| Artal Group S.A. | 760,000 | $2,417,000 | 0.06% |
| ARMISTICE CAPITAL, LLC | 500,000 | $1,590,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 63,114 | $201,000 | 0.04% |
| Cormorant Asset Management, LP | 238,817 | $759,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 1,705,195 | $5,423,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 419,104 | $1,333,000 | 0.01% |